drugset / Trial / NCT07043218
A Clinical Study Exploring Universal CAR-T Cell in Patients With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
Phase 1
Not yet recruiting
36 enrolled
Shanghai Tongji Hospital, Tongji University School of Medicine
NaSingle-groupOpen-labelTreatment
Summary
A Clinical Study to Investigate the Safety, Efficacy, and Cellular Metabolism of CT119X(including CT1190-P and CT1192) CAR-T Cell therapy, in Patients with Relapsed/Refractory B-cell acute lymphoblastic leukemia.
Timeline
- Start
- 2025-07-10
- Primary completion
- 2026-06-30
- Completion
- 2027-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CT119X | Unknown | — | — |